Home MarketFortis Healthcare Ltd.

Fortis Healthcare Ltd. Stock Info: As on 2018-05-24 15:59:59

Nse

142.95

-1.95(-1.35%)
Change%
52 Week Range
107.10
6.00
206.25
26.00
Open145.90
Day's Range115.92 - 173.88
Value Traded (in ₹ Cr.) 28.37

Bse

142.60

-2.05(-1.42%)
Change %
52 Week Range
106.65
6.00
206.25
26.00
Open146.90
Day's Range115.72 - 173.58
Value Traded (in ₹ Cr.) 2.70

Stock Exchange

Category No. Of Shares Share %
ForeignPromoters 0.00 0.00%
IndianPromoters 3,970,870.00 0.77%
Mutual Funds/UTI 23,593,662.00 4.55%
FII 236,678,649.00 45.63%
Employee 0.00 0.00%
Public 82,375,020.00 15.88%
Government 0.00 0.00%
Others 81,994,707.00 15.81%
More

Key Statistics

Valuation Measures
Market Cap / Sales Ratio 14.45
Basic EPS (Rs.) -1.57
Cash EPS -0.92
BVPerShare Excl 82.51
Operating Revenue 12.46
PBDITPerShare 0.43
Dividend 0.00
NPPerShare -1.44
Current Ratio 0.48
Quick Ratio 0.47
PriceToBV 2.18
Earnings -0.01
PBDIT Margin 3.51
PBT Margin -17.67
NP Margin -11.57
Return On Assets -1.44
Retention Ratios 0.00
Parameter Mar-17 (₹ Cr.) Yoy%change
Total Income 814.31
Total Expenses 924.62
EBITDA 22.67
PBT -114.04
PAT -74.70
Net Income -74.70
More
Parameter Sep-17 (₹ Cr.) 6M % change
Total Income 411.53
Total Expenses 373.24
EBITDA 24.55
PBT 3.33
PAT 0.73
Net Income 0.00
More
Total Assets
Total Assets
Parameter Mar-17 (₹ Cr.) Yoy%change
Total share capital 517.73
Net worth 4,271.86
Investments 3,602.67
Total Liability 5,160.96
Total debt 624.87
Net block 384.62
Total Assets 5,160.96
Parameter Mar-17 (₹ Cr.) 6M % change
Total share capital 463.13
Net worth 3,608.27
Investments 2,635.50
Total Liability 4,909.37
Total debt 1,044.54
Net block 349.23
Total Assets 4,909.37
Company Curr Price Prev. Close Change% W's Low/High

Apollo Hospitals Enterprise Ltd.

966.55 963.95 0.27
9571038

Aster DM Healthcare Ltd.

179.6 177 1.47
175.95190.6

Dr. Lal Pathlabs Ltd.

890.05 882.5 0.86
851.25899

Healthcare Global Enterprises Ltd.

304.25 302.8 0.48
300314

Indraprastha Medical Corporation Ltd.

45.75 45.4 0.77
4547.75

Kovai Medical Center and Hospital Ltd.

641.65 624.85 2.68
629.9649.9

Lotus Eye Hospital and Institute Ltd.

29.85 29.75 0.34
27.6530.95
Company Curr Price Prev. Close Change% W's Low/High

ADS Diagnostic Ltd.

11.34 10.8 0
11.3411.34

Apollo Hospitals Enterprise Ltd.

969.75 966.3 0.36
956.851035.7

Aspira Pathlab & Diagnostics Ltd.

17.82 16.98 4.95
17.8217.82

Aster DM Healthcare Ltd.

0 0 0
176.25190.75

Birla Pacific Medspa Ltd.

0.28 0.27 0
0.270.28

CDR Health Care Ltd.

7.58 2.6 0
7.227.58

Chennai Meenakshi Multispeciality Hospital Ltd.

21.8 21.8 0
21.823.8
More
Parameter Mar-17(in ₹ Cr.)
Cash from operating activities 29.13
Cash from investing activities -79.88
Cash from financing activities 47.35
Net change in cash -3.41

Stock Held By Mutual Fund Schemes

Scheme Holding (%)
ICICI Prudential MidCap Fund 2.93%
JM Arbitrage Advantage Fund 1.08%
Reliance Growth Fund 0.53%
Aditya Birla Sun Life Midcap Fund 1.28%
Aditya Birla Sun Life Resurgent India Fund - Series 4 1.26%
ICICI Prudential Value Fund - Series 20 0.06%

M Venkatesh appointed MRPL MD

M Venkatesh has been appointed as the Managing Director of Mangalore Refineries and Petrochemicals Limited (MRPL), an order issued by the Personnel Ministry said today. Vekatesh is at present Director (Refineries) in the MRPL, a subsidiary of the Oil and Natural Gas Corporation Limited (ONGC) He has been appointed to the post for a period of five years with effect from the date of his assumption of charge of the post on or after June 1, 2018, or till the date of his superannuation, the order said.

24-05-2018 11:42

TCS expands operations in Florida as part of Transamerica deal

India's largest IT services firm TCS today said it has expanded operations in Florida, US, with over 430 employees joining the company as part of its deal with Transamerica. In January, Tata Consultancy Services (TCS) had signed an over USD 2 billion deal with Transamerica to administer the latter's life insurance, annuity, supplemental health insurance, and workplace voluntary benefits products. It covered managing administration of more than 10 million policies. More than 430 former Transamerica employees now work for TCS at this new St Petersburg facility (in Florida) as part of recruiting and investing in more than 2,200 Transamerica jobs across the US in multiple locations, the Indian software services giant said in a statement. TCS will occupy several floors of Transamerica's building at 570 Carillon Parkway in St Petersburg, as part of a multi-year agreement with Transamerica... The St Petersburg office is a new US business centre for TCS, adding to the over 1,000 employees already serving American businesses throughout the state, it added. TCS said it has invested nearly USD 3 billion in the US over the past three years and has been among the top two IT services job creators in the country. TCS is a leading industry employer in the US, striving to help American companies like Transamerica to digitally transform their business and capitalise on rapidly evolving customer demands, TCS President and Global Head (Banking, Financial Services and Insurance Platforms) Suresh Muthuswami said. We look forward to partnering with St Petersburg's city, state and local organizations to further build upon our business and community impact, he added. The company said it has made tremendous community impact in Florida over past several years.

24-05-2018 11:16

Kotak India Growth Fund Series 4 - Direct Plan: change in investment factsheets for April

Kotak India Growth Fund Series 4 - Direct Plan has announced change in investment factsheets and fund flash for the month ended April 30, 2018. As on Apr 30, 2018, the total size of the Fund was Rs 429.99 crores, compared with Rs 424.96 crores in the last month. The Fund's NAV per unit was Rs 9.89 for Growth, while 52-Week High and Low ranges were Rs 10.35 and Rs 9.51 respectively. The Equity - Diversified fund with Growth plan was launched on Jan 29, 2018 and managed by Fund Managers Harsha Upadhyaya, Devender Singhal. The top five companies based on a percentage of total holdings were ITC Ltd. (35.18 Cr.), HDFC Bank Ltd. (19.44 Cr.), Mahindra & Mahindra Ltd. (19.21 Cr.), Tata Motors Ltd. (17.02 Cr.) and Bata India Ltd. (16.05 Cr.). Kotak India Growth Fund Series 4 - Direct Plan is promoted by Kotak Mahindra Mutual Fund and managed by Kotak Mahindra Asset Management Company Ltd..

24-05-2018 11:00

Kotak India Growth Fund Series 4: change in investment factsheets for April

Kotak India Growth Fund Series 4 has announced change in investment factsheets and fund flash for the month ended April 30, 2018. As on Apr 30, 2018, the total size of the Fund was Rs 429.99 crores, compared with Rs 424.96 crores in the last month. The Fund's NAV per unit was Rs 9.88 for Growth, while 52-Week High and Low ranges were Rs 10.34 and Rs 9.51 respectively. The Equity - Diversified fund with Growth plan was launched on Jan 29, 2018 and managed by Fund Managers Harsha Upadhyaya, Devender Singhal. The top five companies based on a percentage of total holdings were ITC Ltd. (35.18 Cr.), HDFC Bank Ltd. (19.44 Cr.), Mahindra & Mahindra Ltd. (19.21 Cr.), Tata Motors Ltd. (17.02 Cr.) and Bata India Ltd. (16.05 Cr.). Kotak India Growth Fund Series 4 is promoted by Kotak Mahindra Mutual Fund and managed by Kotak Mahindra Asset Management Company Ltd..

24-05-2018 11:00

BLS International to assist Sopra Steria on UK visa renewals

Visa service provider BLS International today said theUnited Kingdom Visas and Immigration (UKVI) has awarded Sopra Steria a new contract to enable visa renewals for those individuals who are already in the UK. BLS International will support Sopra Steria and UKVI, a division of the UK Home Office responsible for deciding who can visit and stay within the UK, by establishing and delivering some of the key add value services under the contract, it said in a release. BLS International claims to handle about 12 million visa applications annually across the globe at present. Meanwhile, shares of the company were trading at Rs 172.55 apiece, up 1 per cent from the previous close at 10:50 hours on BSE.

24-05-2018 10:51

Fortis Healthcare - Fortis Healthcare Ltd reply to clarification sought by the exchange

The Exchange had sought clarification from Fortis Healthcare Ltd with respect to news article appearing on www.hindustantimes.com - May 22, 2018 SEBI probes insider trading violation, other regulatory lapses at Fortis Healthcare.

Fortis Healthcare Ltd response is enclosed.

24-May-2018 09:46 AM

Fortis Healthcare - Updates

Fortis Healthcare Limited has informed the Exchange regarding ''Regulation 30 Update ? TPG-Manipal?s New Offer''.This is in continuation to our letter Ref. No. FHL/SEC/STEX/RR/2018-19 dated April 25, 2018 and May 6, 2018 whereby, it was informed that the Board of Directors of Fortis Healthcare Limited (?the Company?) has received Revised Offer from Manipal and TPG with a proposal to invest in the Company.It is hereby informed that the Company today i.e. May 14, 2018, has received a New Offer, as attached herewith.We will keep the stock exchanges updated/informed in terms of Regulation 30 of the SEBI(Listing Obligations and Disclosure Requirements) Regulations, 2015.This is for your information and records please. We assure you of our full cooperation at alltimes.You are kindly requested to take the same on record.

23-May-2018 10:48 PM

Fortis Healthcare - News Clarification

The Exchange had sought clarification from the Company with respect to news item captioned- SEBI probes insider trading violation, other regulatory lapses at Fortis Health. The response from the Company is attached.

23-May-2018 08:53 PM

Fortis Healthcare - Updates

Fortis Healthcare Limited has informed the Exchange regarding ''Notice of Board Meeting under Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015''.Pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Notice is hereby given that a meeting of the Board of Directors of the Company will be held on Wednesday, May 30, 2018 to, inter-alia, consider and approve the Audited Financial Results for the quarter and financial year ended March 31, 2018.Further, the trading window of the Company for dealing in securities of the Company will remain closed from May 24, 2018 to June 1, 2018 (both days inclusive).This is for your information and record please.

23-May-2018 08:49 PM

Fortis Healthcare - News Clarification

The Exchange has sought clarification from the Company with respect to news item captioned- SEBI probes insider trading violation, other regulatory lapses at Fortis Health In this regard, Exchange has advised the Company to provide clarification/confirmation on the news item in detail including the following: a) Whether such event/negotiations/article stated in published news were taking place? If so, you are advised to provide the said information along with the sequence of events in chronological order and the material impact of this article on the Company. b) Whether company is aware of any information that has not been announced to the Exchanges under regulation 30 of Listing Regulations. The response from the Company is awaited.

23-May-2018 03:11 PM

Fortis Healthcare - Fortis Healthcare Ltd reply to clarification sought by the exchange

The Exchange had sought clarification from Fortis Healthcare Ltd with respect to news article appearing on www.hindustantimes.com - May 22, 2018 SEBI probes insider trading violation, other regulatory lapses at Fortis Healthcare.

Fortis Healthcare Ltd response is enclosed.

24-May-2018 09:46 AM

Fortis Healthcare - Clarification sought from Fortis Healthcare Ltd

The Exchange has sought clarification from Fortis Healthcare Ltd with respect to news article appearing on www.hindustantimes.com - May 22, 2018 titled SEBI probes insider trading violation, other regulatory lapses at Fortis Healthcare.

The reply is awaited.

23-May-2018 01:51 PM

Fortis Healthcare - Submission Of Details Regarding The Voting Results Of Extra-Ordinary General Meeting Held On May 22, 2018

With reference to the captioned subject, please find enclosed the results of the postal ballot in the prescribed format along with Scrutinizer's report as 'Annexure 1'.

Please note that the Directors proposed to be removed at Resolution No. 5 (Removal of Mr. Harpal Singh), 6 (Removal of Ms. Sabina Vaisoha) and 7 (Removal of Lt. Gen. Tejinder Singh Shergill) had tendered their resignation prior to the date of the meeting of EGM and thereby ceased to be directors of the Company. Accordingly, the said resolutions for their removal become infructuous.

23-May-2018 01:20 PM

Corporate Details

About Management

The registered office of the Company was initially situated at 25, Nehru Place, New Delhi 110 019, India. Pursuant to a Board resolution dated September 16, 2003 the registered office was shifted to B- 9, Maharani Bagh, New Delhi 110 065, India. Subsequently, pursuant to Board resolution dated February 10, 2006 the registered office of the Company was shifted to Piccadily House, 275- 276, 4th Floor, Captain Gaur Marg, Srinivas Puri, New Delhi 110 065, India, which is the current Registered Office. Scheme of merger/amalgamation between Fortis Medical Centre Holdings Limited and the Company dated October 7, 2005: The High Court of Delhi, through its order dated October 7, 2005 in respect of the company petition (C.P. No: 240/2005 and 241/2005) approved the scheme of amalgamation/merger between the Company and Fortis Medical Centre Holdings Limited ("FMCHL"), and which at the time of amalgamation was our board controlled subsidiary, with effect from April 1, 2004 ("Scheme"). Salient features of the Scheme: The principal terms of the Scheme, as sanctioned by the High Court of Delhi, are set forth below: The entire undertaking and business, all properties, tangible and intangible assets including trademarks, patents, design, copyrights, investments, approvals, licenses, tax benefits, pending projects, debts, liabilities and obligations, including income tax liabilities accrued or to accrue in FMCHL was transferred to the Company with effect from April 1, 2004. Pursuant to the Scheme, Fortis Hospital, Amritsar was transferred to the Company. However, the transfer of the aforesaid was subject to the existing charges or hypothecation in respect of the assets of FMCHL. All the staff, workmen and employees of FMCHL in employment on the date immediately preceding December 23, 2005 (i.e., the date on which a certified copy of the order of the High Court of Delhi was filed with the RoC) became the employees of the Company without any break or discontinuity in service and on conditions not less favourable than those subsisting at FMCHL. In consideration of the transfer and vesting of the undertaking and the assets and liabilities of FMCHL and in consideration of the mutual covenants agreed to in the Scheme, the Company agreed to allot the Equity Shares to the existing shareholders of FMCHL, in the ratio of 1:4 (i.e., one Equity Share in exchange of every four equity shares of FMCHL of Rs. 10 each). In compliance with the Scheme, the Company allotted 520,000 Equity Shares to the shareholders of erstwhile FMCHL on February 10, 2006. Major Events: Year Event June 2001 Commissioning of Fortis Hospital, Mohali. August 2003 Inauguration and commissioning of Fortis Hospital, Amritsar. October 2003 Executed an agreement with Seth Jessa Ram and Bros Charitable Hospital Trust for the operation and management of Jessa Ram Hospital, New Delhi. August 200 Commissioning of Fortis Hospital, Noida. September 2005 Acquired 90% of the equity share capital of Escorts Heart Institute and Research Centre Limited resulting in the acquisition of EHCL, EHSSIL, EHSSHL and EHRCL. October 2005 Signed an agreement with Jeewan Mala Hospital Private Limited for the operation and maintenance of Jeewan Mala Hospital, New Delhi. January 2006 Signed an agreement with Sunrise Medicare Private Limited for the operation and management of Fortis La Femme, New Delhi, and acquisition of 5% equity interest in Sunrise Medicare Private Limited, with an option to acquire additional equity shares. January 2006 Signed an agreement with Khalil Public Welfare Trust for the operation and maintenance of Khyber Medical Institute, Srinagar. March 2006 Acquired 99.99% of the paid up equity share capital of International Hospital Limited resulting in the acquisition of Fortis Hospital, Noida. March 2006 Acquired 100.00% of the paid up equity share capital of Oscar Bio-Tech Private Limited. 2004 -Fortis inks deal with Jessa Ram Hospital to takeover the management of the hospital 2005 -Fortis Hospital rolls out Golden Age Club -Fortis buys Escorts Heart -Fortis Healthcare signs $33.33m pre-IPO deals The Company was incorporated on February 28, 1996 as Rancare Limited under the Companies Act. Subsequently on June 20, 1996 our name was changed to our present name-Fortis Healthcare Limited. The Company received the certificate of commencement of business on July 1, 1996. 2006 -Fortis Healthcare to buy majority stake in Trehan`s Medicity -Fortis Healthcare signs $33.33m pre-IPO deals 2007 -Fortis HealthWorld has joined hands with US hearing aid maker Starkey for its Audible range and is looking to soon offer dental services at its Health stores too. -Colgate-Palmolive India, the market leader in toothpaste in India, declared the acquisition of three domestic companies in south India recently. The company purchased 75 per cent equity in Advanced Oral Care Products (Goa), Professional Oral Care Products (Goa) and SS Oral Hygiene Products (Hyderabad). -Fortis Healthcare acquires Hiranandani Hospital 2008 -Fortis Healthcare Ltd has informed that the Board of Directors of the Company at its meeting held on January 23, 2008, inter alia, has approved change in registered office of the Company from "Piccadily House, 275-276, 4th Floor, Captain Gaur Marg, Srinivas Puri, New Delhi - 110065" to "Escorts Health Institute And Research Centre, Okhla Road, New Delhi - 110025". 2009 -Fortis completes Wockhardt Hospital Acquisition -Fortis signs $15 mn outsourcing deal with HCL -Fortis Healthcare Ltd Issues Rights in the Ratio of 2:5 2010 - 25% stake in Parkway holdings, Asia's largest private healthcare provider. - "Fortis Healthcare infuses USD 100 Million". - Fortis increases stake in Parkway. - Government of Singapore Investment Corp (GIC) to join hands with Fortis at strategic level. - Fortis Healthcare has entered into a pact with two hospitals in Dubai and Tanzania to set up specialised medical facilities. - Company has announced its foray into Speciality Medical Centres focused on the management of diabetes, metabolic diseases and endocrinology. 2011 - A Memorandum of Understanding has been signed by Fortis Healthcare Ltd with the University of Utah to develop courses for Emergency Medical Technicians. - Through its wholly owned subsidiary, has entered into an agreement with Cauvery Hospital Limited, Mysore, wherein Fortis will set up, operate and manage a Cardiac Centre in the hospital. - The name of Fortis Healthcare Limited shall be changed to Fortis Healthcare (India) Limited w.e.f. April 11, 2011. - "Fortis Healthcare ties up with TotipotentRX to set up Stem Cell Therapy Centres". - Fortis Healthcare (India) Ltd has announced that it will buy 86 per cent stake in Super Religare Laboratories Ltd (SRL) . - Fortis Healt - Fortis announces new hospitals in Hyderabad and Agra. 2012 - "Fortis to get Rs. 3700 Mn Equity infusion in SRL through IFC and NYLIM Jacob Ballas India". - Fortis Healthcare raises around S$510 mn through Singapore IPO. -Company has changed its name from Fortis Healthcare (India) Ltd. to Fortis Healthcare Ltd. 2013 -"Fortis launches its Flagship Hospital, One of the First of its Kind in Asia Bridges the gap for expert talent, trans-disciplinary, quaternary care". -"Fortis to divest stake in Quality Healthcare to Bupa for US$ 355 million Intensifies Focus on Healthcare Delivery in India". 2014 -"Fortis launches state of the art, multi super-specialty hospital in Ludhiana". 2016 -Fortis Healthcare has fully acquired Religare Health Trust Trustee Manager for USD 14.9 million (about Rs 100 crore). -Fortis group gets CCI nod for internal reorganisation. -Fortis Healthcare First in India to Monitor and Publish Clinical Outcomes for Cardiology. -Fortis Healthcare launches National helpline for students and parents to help deal exam stress. 2017 -Fortis Healthcare Acquisition of Hiranandani Healthcare Private Limited,Fortis Healthcare Holdings Private Limited and RHC Holding Private Limited.

Registered Office

Fortis-Escorts Hospital: 2nd Floor, Coronation Hospital, Curzon Road,

,,,      ,

Registrar Details

Karvy Computershare Private Ltd.